Since Pfizer’s Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the essential but troubled injectables facility.
Pfizer has committed to building a massive, $465 million sterile manufacturing plant at its site in Michigan that is expected to add 450 new jobs by the time it is fully operational.